Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Stock Information for Biodesix Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Biodesix Inc.

Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026
Biodesix Recognized as a Top Workplace for Third Consecutive Year
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
Biodesix to Participate in Upcoming Investor Conferences
Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.